| 1. |
Chen W, Zheng R, Zeng H, et al. The incidence and mortality of major cancers in China, 2012. Chin J Cancer, 2016, 35(1): 73-76.
|
| 2. |
Salem AI, Alfi M, Winslow E, et al. Has survival following pancreaticoduodenectomy for pancreas adenocarcinoma improved over time? J Surg Oncol, 2015, 112(6): 643-649.
|
| 3. |
Strobel O, Hank T, Hinz U, et al. Pancreatic cancer surgery: the new r-status counts. Ann Surg, 2017, 265(3): 565-573.
|
| 4. |
Chang DK, Johns AL, Merrett ND, et al. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol, 2009, 27(17): 2855-2862.
|
| 5. |
Verbeke C, Leitch D, Menon K, et al. Redefining the R1 resection in pancreatic cancer. Br J Surg, 2006, 93(10): 1232-1237.
|
| 6. |
Mathur A, Ross SB, Luberice K, et al. Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued. Am Surg, 2014, 80(4): 353-360.
|
| 7. |
Petrucciani N, Nigri G, Debs T, et al. Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatic, 2016, 16(6): 1037-1043.
|
| 8. |
Nitschke P, Volk A, Welsch T, et al. Impact of intraoperative resection to achieve R0 status on survival in patients with pancreatic cancer: a single-center experience with 483 patients. Ann Surg, 2017, 265(6): 1219-1225.
|
| 9. |
Siriwardana HP, Siriwardena AK. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg, 2006, 93(6): 662-673.
|
| 10. |
Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol, 2009, 16(7): 1736-1744.
|
| 11. |
Toomey P, Hernandez J, Morton C, et al. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg, 2009, 75(9): 804-810.
|
| 12. |
Tang D, Zhang JQ, Wang DR. Long term results of pancreatectomy with portal-superior mesenteric vein resection for pancreatic carcinoma: a systematic review. Hepatogastroenterology, 2011, 58(106): 623-631.
|
| 13. |
Riediger H, Makowiec F, Fischer E, et al. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg, 2006, 10(8): 1106-1115.
|
| 14. |
Banz VM, Croagh D, Coldham C, et al. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas. Eur J Surg Oncol, 2012, 38(1): 72-79.
|
| 15. |
Chen Y, Wang X, Ke N, et al. Inferior mesenteric vein serves as an alternative guide for transection of the pancreatic body during pancreaticoduodenectomy with concomitant vascular resection: a comparative study evaluating perioperative outcomes. Eur J Med Res, 2014, 19(1): 42.
|
| 16. |
Van den Broeck A, Sergeant G, Ectors N, et al. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol, 2009, 35(6): 600-604.
|
| 17. |
Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg, 2004, 8(8): 935-949.
|
| 18. |
Turrini O, Ewald J, Barbier L, et al. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma? Ann Surg, 2013, 257(4): 726-730.
|
| 19. |
Mollberg N, Rahbari NN, Koch M, et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg, 2011, 254(6): 882-893.
|
| 20. |
Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg, 1998, 228(4): 508-517.
|
| 21. |
Jang JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg, 2014, 259(4): 656-664.
|
| 22. |
Michalski CW, Kleeff J, Wente MN, et al. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer.. Br J Surg, 2007, 94(3): 265-273.
|
| 23. |
Ke K, Chen W, Chen Y. Standard and extended lymphadenectomy for adenocarcinoma of the pancreatic head: a meta-analysis and systematic review. J Gastroenterol Hepatol, 2014, 29(3): 453-462.
|
| 24. |
Iqbal N, Lovegrove RE, Tilney HS, et al. A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a meta-analysis of 1 909 patients. Eur J Surg Oncol, 2009, 35(1): 79-86.
|
| 25. |
Svoronos C, Tsoulfas G, Katsourakis A, et al. Role of extended lymphadenectomy in the treatment of pancreatic head adenocarcinoma: review and meta-analysis. ANZ J Surg, 2014, 84(10): 706-711.
|
| 26. |
Tol JA, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 2014, 156(3): 591-600.
|
1/5
WeChat